Diabetes

Onglyza (saxagliptin), developed by AstraZeneca, was found to cause an increased risk of heart failure.

Incentives in employee wellness programs, especially penalties, can hurt morale and lead to legal action. But without incentives, there's no guarantee the employer will see healthcare savings and return on investment.

Hospitals like Boston Children's and Penn Medicine think they are better off building in-house apps that are custom-made for their workflow, rather than risk buying those available in the market, which may not necessarily be a perfect fit.

Researchers worked with nearly 3800 individuals to establish workplace programs that focused on healthy eating and increasing physical activity. At the end of the study period, the number of employees in the control site who were overweight/obese increased by about 5%, while the number in the intervention group had decreased by 4%, resulting in a net difference of 9%.

Quality benefits were equal across racial/ethnic groups with equal personal health record (PHR) use, but nonwhite status and a preference for Spanish language predicted lower PHR registration.

The study found that thiazolidinediones, commonly used to treat individuals suffering from type 2 diabetes, activate the PPARY' receptors in the hypothalamus, which in turn triggers food hoarding, food intake.

Diabetic retinopathy affects 33% of all patients with diabetes over 40; 29 million Americans have type 1 or type 2 diabetes.

This article identifies patient-, provider-, and system-level factors associated with the problem of self-monitoring blood glucose without use of the results.

Diabetes is associated with more advanced stage breast cancer, according to a new study that confirms a strong link between diabetes and later stage breast cancer at diagnosis.

The Association for Molecular Pathology has provided comments to the FDA, urging increased regulation of next generation sequencing diagnostic tests to ensure consistent and proper performance of the tests.

The study, conducted by the national laboratory Quest Diagnostics, found that in states that expanded Medicaid, he number of Medicaid enrollees with newly identified diabetes rose by 23%, to 18,020 in the first 6 months of 2014, from 14,625 in the same period in 2013.

A one-minute look at managed care news during the week of March 16, 2015, including bills from Congress to fix the sustainable growth rate formula and anticipation over the PCSK9 inhibitors.

Targeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.

A study that combined socioeconomic data and hospital-level data on quality care after myocardial infarction showed that hospitals that serve the poorest Americans adhere to high standards, but patient outcomes do not always reflect that high-quality acute care.

An estimated 86 million Americans have prediabetes and 90% don't know it. The initiative announced yesterday seeks to reach this population and intervene before the disease progresses to type 2 diabetes mellitus, which costs $245 billion a year.

A new analysis published by the RAND Corporation suggests strategies that the pharmaceutical industry could offer payers as they try to cover the front-loaded cost of newer breakthrough drugs.

A unique coaching project included not only traditional elements like nutrition and exercise but also stress management and sleep.

The study, which will presented next week at the meeting of the American College of Cardiology, defined how much avoiding diabetes, obesity, and hypertension before age 45 matters if one is later diagnosed with heart failure.

While the pharmaceutical industry has always justified the billions spent on developing a candidate drug molecule, the process has definitely seen some important changes. This article evaluates whether these revolutionary changes have influenced drug development for the better.

This study's findings showed that diabetes care remained suboptimal among many patients with multiple chronic conditions and that patient outcomes varied by multimorbidity profile.

Budget cuts mean county health clinics will be unable to fill hundreds of jobs, leaving smaller staffs to serve low-income people in state that declined to expand Medicaid despite pleas from its hospitals and business leaders.

Significant results from an international phase 3 study, EDITION, resulted in the approval of Toujeo in treating patients with type 1 as well as type 2 diabetes.

The 2015 Dietary Guidelines Advisory Committee met for more than a year to review scientific evidence and discuss "patterns" of food consumption, and those discussions are reflected in the report. After a 45-day comment period and public hearing, the US Secretaries of Agriculture and Health and Human Services will issue the final Dietary Guidelines for Americans, the nation's official nutrition policy.

Study finds that Regeneron Pharmaceuticals' more expensive Eylea help patients with severe eye disease caused by diabetes more than the less-expensive options from Roche Holding.

The study, conducted at the Columbia University School of Nursing, found that mobile apps with decision support features resulted in significantly higher diagnosis rates than apps with only bare-bones tools for recording results from a patient exam.

Developed by the company 23andMe, the test identifies carriers of a gene mutation that could determine the susceptibility of a person's offspring to Bloom Syndrome.

The article was part of a Lancet series which took aim at the "unacceptably slow" response to rising rates of childhood obesity, and the effects not only on health but also on its social and economic effects on children. Authors called on nations to rein in marketing aimed at children.

A randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.

A one-minute look at managed care news during the week of February 9, 2015, including an announcement of a new Affordable Care Initiative and a potential change to recommended dietary guidelines.

This retrospective cohort study in a Medicare Advantage population posits that type 2 diabetes mellitus complications pose an excess burden on healthcare resource use and related costs.